Chuck Royce's position in Cellebrite DI Ltd is currently worth $9.17 Million. That's 0.08% of their equity portfolio (331st largest holding). The stake costed the investor $3.98 Million, netting the investor a gain of 130% so far.
Avg closing price
Price range
Increased shares by 4.5% (+34.3 Thousand shares)
Q1 2024
Avg closing price
$10.21
Price range
$8.04
-
$12.29
Increased shares by 15.1% (+100 Thousand shares)
Q2 2023
Avg closing price
$5.83
Price range
$5.30
-
$7.20
Increased shares by 17.8% (+100 Thousand shares)
Q1 2023